Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $8.56 and last traded at $8.56, with a volume of 569287 shares trading hands. The stock had previously closed at $7.75.
Cybin Price Performance
The firm has a market cap of $1.27 billion and a P/E ratio of -0.85. The firm’s 50 day moving average is $0.26 and its 200 day moving average is $0.32.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Featured Stories
- Five stocks we like better than Cybin
- Best Stocks Under $5.00
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- How to Use the MarketBeat Dividend Calculator
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
